Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin and Misoprostol vs Alone for PPH Prevention in C-Section
NCT01571323Phase 2Completed
- Sponsor
- Qazvin University of Medical Sciences
- Start
- Feb 2012
- Primary completion
- Aug 2012
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of oxytocin and misoprostol in postpartum hemorrhage (PPH) (3 arms), sponsored by Qazvin University of Medical Sciences. Primary endpoints: Blood loss at cesarean section and Changes in hemoglobin levels at 24 hours. Started Feb 2012; status: completed.
02
Drugs
oxytocinmisoprostol
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on NCT01571323.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01571323.